Minimal increases of alpha-fetoprotein strongly predict HCC development in caucasian compensated HBV cirrhotics treated by entecavir or tenofovir: A 7-year longitudinal cohort study in 225 patients. Issue 1 (16th February 2017) - Loglio, A.; Grossi, G.; Iavarone, M.; Viganò, M.; Sangiovanni, A.; Colombo, M.; Lampertico, P.